1 min read
Webinar: Regulatory Strategy for New Neurological Medical Devices
Joana Gomes : Mar 24, 2025 10:22:44 PM

Regulatory Strategy for New Neurological Medical Devices
Considerations for an effective balance between non-clinical and pre-clinical evaluations
- has a high degree of invasiveness;
- has novel features or requires a novel surgical procedure;
- is complex and expensive to produce, such as in the case of active implantable medical devices or implantation devices within the field of neurology.
In this recorded webinar, Dr Olivier Chevènement and Dr Richard Curno from Veranex discuss:
- the most common regulatory challenges faced by medical device companies;
- a typical approach to developing a regulatory strategy, which includes the design and planning of V&V and pre-clinical evaluations in support of the conduct and planning of a first-in-human investigation;
- common strategies and considerations to find an economical and efficient balance between non-clinical and preclinical evaluations;
- common synergies between different aspects of non-clinical evaluations, including test device selection and use of dummies, as well as pre-clinical study design and considerations that can be supportive of the regulatory strategy.
Please submit the form to view the webinar:
ICER Set to Evaluate Non-Drug Products in 2020
The Boston-based Institute for Clinical and Economic Review (ICER), an independent research organization that conducts health technology assessments...

4 min read
Rescue Studies: Salvaging Clinical Trials Through Expert Data Management
When a clinical trial faces data quality challenges, every day counts. Rescue studies have become an increasingly critical component in...